Search Within

CTCR Scholars

  1. "Molly Maloy"
Formats
  1. Meeting Abstract (112)
  2. Journal Article (60)
  3. Research Letter (5)
Groups
  1. Department of Medicine (177)
  2. DigITs Research Group (177)
  3. Hematologic Malignancies, Division of (176)
  4. Bone Marrow Transplant (175)
  5. Center for Hematologic Malignancies (175)
  6. MSK Grad Students (149)

More Groups

People
  1. Molly Maloy (177)
  2. Sergio Giralt (164)
  3. Miguel-Angel Perales (145)
  4. Sean Devlin (120)
  5. Craig Sauter (90)
  6. Ann Jakubowski (85)

More People

Years
  1. 2023 (1)
  2. 2022 (7)
  3. 2021 (14)
  4. 2020 (34)
  5. 2019 (38)
  6. 2018 (30)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (82)
  2. Blood (38)
  3. Bone Marrow Transplantation (22)
  4. Blood Advances (11)
  5. Leukemia and Lymphoma (5)
  6. Transplantation and Cellular Therapy (4)

More Publications

Publishers
  1. Elsevier Inc. (86)
  2. American Society of Hematology (49)
  3. Nature Publishing Group (25)
  4. Taylor & Francis Group (5)
  5. American Society of Clinical Oncology (3)
  6. Wiley Blackwell (2)

More Publishers

Results (177)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic factors of CLL patients undergoing reduced intensity allogeneic hematopoietic stem cell transplantation in the immunochemotherapy era
    Meeting Abstract

    Lahoud, O. B.; Hilden, P.; Maloy, M. A.; Dahi, P. B.; Castro-Malaspina, H.; Perales, M. A.; Giralt, S. A.; Sauter, C. S.
    Blood (2016)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation is underutilized in patients with myelodysplastic syndromes
    Meeting Abstract

    Getta, B.; Kishtagari, A.; Hilden, P.; Devlin, S.; Maloy, M. A.; Gonzales, P. K.; Shaffer, B. C.; Ponce, D. M.; Gyurkocza, B.; Barker, J. N.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • The Disease Risk Index predicts outcomes including relapse and survival in CD34-selected allogeneic HCT for acute leukemia and myelodysplastic syndrome
    Meeting Abstract

    Cho, C.; Hilden, P.; Peled, J. U.; Avecilla, S. T.; Barba, P.; Barker, J. N.; Castro-Malaspina, H. R.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Low incidence of GvHD with T-cell depleted allografts facilitates further treatments for post-transplantation relapse in AML and MDS
    Journal Article

    Dahi, P. B.; Morawa, E.; Perales, M. A.; Zabor, E. C.; Devlin, S. M.; Maloy, M.; Castro-Malaspina, H.; O'Reilly, R. J.; Papadopoulos, E. B.; Jakubowski, A. A.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • CD34+ selected ex-vivo T-cell depleted grafts for allogeneic hematopoietic cell transplantation is associated with low incidence of acute and chronic graft-versus-host disease (GVHD) and high chronic-GVHD/relapse-free survival
    Meeting Abstract

    Barba, P.; Hilden, P.; Devlin, S.; Maloy, M.; Barker, J.; Castro-Malaspina, H.; Jakubowski, A.; Koehne, G.; Papadopoulos, E.; Sauter, C.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Late toxicities in long-term survivors of adult allogeneic hematopoietic cell transplantation (allo-HCT) using ex-vivo CD34+ selection-based graft-versus-host disease (GVHD) prophylaxis
    Meeting Abstract

    Scordo, M.; Shah, G. L.; Devlin, S.; Maloy, M.; Kosuri, S.; Herrera, D. A.; Nieves, J.; Avecilla, S. T.; Meagher, R. C.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Acute toxicities in patients receiving ex-vivo CD34+ selected allogeneic stem cell transplantation for hematologic malignancies
    Meeting Abstract

    Herrera, D.; Perales, M. A.; Shah, G.; Scordo, M.; Devlin, S.; Maloy, M.; Nieves, J.; Avecilla, S.; Meagher, R.; Gyurkocza, B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Toxicities in older adult patients undergoing CD34+ selected allogeneic hematopoietic stem cell transplantation (allo-HCT)
    Meeting Abstract

    Shah, G. L.; Scordo, M.; Kosuri, S.; Herrera, D. A.; Maloy, M.; Nieves, J. L.; Devlin, S.; Avecilla, S. T.; Meagher, R.; Shaffer, B.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Sirolimus, tacrolimus and low-dose methotrexate as GVHD prophylaxis is safe and associated with promising results in patients receiving reduced-toxicity allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Avila, A. M.; Barba, P.; Cho, C.; Devlin, S.; Ceberio, I.; Ponce, D.; Maloy, M.; Perales, M. A.
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts outcomes in patients with acute myeloid leukemia and myelodysplastic syndromes receiving CD34+ selected grafts for allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Barba, P.; Ratan, R.; Ceberio, I.; Hilden, P.; Devlin, S.; Maloy, M.; Barker, J.; Castro-Malaspina, H.; Jakubowski, A.; Koehne, G.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save